News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MediBiC And Threshold Pharmaceuticals, Inc. Conclude Co-Development Agreement For Glufosfamide


10/19/2005 5:09:37 PM

Tokyo (JCNN) - MediBIC (TSE:2369) announced December 24 that it has signed a co-development agreement with US bio-venture company Threshold Pharmaceuticals.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES